Previous 10 | Next 10 |
Shares of Amyris (NASDAQ:AMRS) are down 30% in Tuesday afternoon trading following Q1 2022 earnings results that missed on the top and bottom lines. The synthetic biotechnology company saw its net loss in the quarter narrow ~62% $110.2M (-$0.34 loss per share, basic) compared to the...
Amyris press release (NASDAQ:AMRS): Q1 Non-GAAP EPS of -$0.37 misses by $0.16. Revenue of $57.7M (-67.4% Y/Y) misses by $7.75M. Adjusted EBITDA of -$107.5 million decreased $66.2 million. Non-GAAP core gross margin of $26.8 million, or 46% of revenue, increased from $17.0 million, or 51% of r...
AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS PR Newswire Record consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 EMERYVILLE, Calif. ...
Amyris (NASDAQ:AMRS) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is -$0.21 and the consensus Revenue Estimate is $65.45M (-63.0% Y/Y). Over the last 2 years, AMRS has beaten EPS estimates 25% of the time and has beaten...
Gainers: Mesa Royalty (MTR) +21%. DMC Global (BOOM) +18%. NRG Energy (NRG) +7%. Earthstone Energy (ESTE) +6%. Northern Oil and Gas (NOG) +6%. Losers: Compass Minerals International (CMP) -16%. Clean Energy Fuels (CLNE) -14%. Origin Agritech (SEED) -12%. Amyris (AMRS) -10%. NextDecad...
AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10 PR Newswire EMERYVILLE, Calif. , May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustai...
2022 is the year of the “Brick” for Amyris as it completes construction of the World's Largest Fermentation Plant, Consumer Production Facilities, and entry into global “Brick-and-Mortar” Retail Chain Stores. Amyris continues to achieve scale across Geograp...
AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT PR Newswire EMERYVILLE, Calif. , April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...
AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT PR Newswire EMERYVILLE, Calif. , April 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable co...
Shares of Amyris Inc. (NASDAQ:AMRS) traded today at $23.33, eclipsing its 52-week high. So far today approximately 298.6 million shares have been exchanged, as compared to an average 30-day volume of 4.5 million shares. Amyris Inc. share prices have moved between a 52-week high of $18.75...
News, Short Squeeze, Breakout and More Instantly...
2023-08-14 06:00:00 ET 3 Tips for New Penny Stocks Traders Penny stocks, often priced below $5 per share, present an enticing opportunity for investors looking to diversify their portfolios and potentially reap significant returns. While these stocks can be volatile, with the right stra...
2023-08-12 06:54:00 ET 3 Tips for Predicting When a Penny Stock Will Breakout in Price Penny stocks, often priced below $5, have garnered significant attention from investors due to their potential for substantial returns. Predicting breakouts in penny stocks can be both an art and ...
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION PR Newswire Voluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris' Core Business $190 Million Financing Commitment from Foris Ventures to Support...